Skip to main content
. 2016 Dec 9;8(6):512–517. doi: 10.5114/jcb.2016.64511

Table 2.

Acute and late vaginal toxicity after adjuvant high dose rate (HDR) vaginal brachytherapy (21 Gy delivered in three fractions)

Grading Acute toxicity
G1 G2 G3 Any G
Vaginal inflammation 14 4 0 18 (14.3%)
Dyspareunia 6 1 0 7 (5.5%)
Hemorrhage 0 1 0 1 (0.8%)
All 20 (15.8%) 6 (4.8%) 0 (0%) 26 (20.6%)
Grading Late Toxicity
G1 G2 G3 Any G
Dryness 4 2 0 6 (4.8%)
Telangiectasias 6 1 0 7 (5.5%)
Fibrosis 13 1 0 14 (11.1%)
Stenosis 2 0 0 2 (1.6%)
All 25 (19.9%) 4 (3.1%) 0 29 (23.0%)